Genetic polymorphisms of cytochrome P450-1A2 (CYP1A2) among Emiratis

• Published in: PloS one Vol. 12; no. 9; p. e0183424
• Main Authors: Al-Ahmad, Mohammad M., Amir, Naheed, Dhanasekaran, Subramanian, John, Anne, Abdulrazzaq, Yousef M., Ali, Bassam R., Bastaki, Salim M. A.
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 21.09.2017; Public Library of Science (PLoS)
• Subjects: Adolescent; Adult; Alleles; Analysis; Biology and Life Sciences; Caffeine; Caffeine - metabolism; Cancer; Chromatography; CYP1A2 protein; Cytochrome; Cytochrome P-450; Cytochrome P-450 CYP1A2 - genetics; Cytochrome P450; Drugs; Emirians; Enzymes; Female; Gene frequency; Genetic aspects; Genetic polymorphisms; Genotype; Genotypes; Haplotypes; Health sciences; Heterozygotes; High performance liquid chromatography; Humans; Liquid chromatography; Male; Medicine; Medicine and Health Sciences; Metabolism; Metabolites; Middle Aged; Oxidase; Pharmacology; Phenotype; Phenotyping; Physical Sciences; Physiological aspects; Polymorphism, Single Nucleotide; Population; Population genetics; Proteins; Psychotropic drugs; Research and Analysis Methods; Social Sciences; United Arab Emirates; Urine; Young Adult; United Arab Emirates; Abu Dhabi United Arab Emirates
• DOI: 10.1371/journal.pone.0183424
• ISSN: 1932-6203

Cytochrome P450 1A2 (CYP1A2) is one of the CYP450 mixed-function oxidase system that is of clinical importance due to the large number of drug interactions associated with its induction and inhibition. In addition, significant inter-individual differences in the elimination of drugs metabolized by CYP1A2 enzyme have been observed which are largely due to the highly polymorphic nature of CYP1A2 gene. However, there are limited studies on CYP1A2 phenotypes and CYP1A2 genotypes among Emiratis and thus this study was carried out to fill this gap. Five hundred and seventy six non-smoker Emirati subjects were asked to consume a soft drink containing caffeine (a non-toxic and reliable probe for predicting CYP1A2 phenotype) and then provide a buccal swab along with a spot urine sample. Taq-Man Real Time PCR was used to determine the CYP1A2 genotype of each individual. Phenotyping was carried out by analyzing the caffeine metabolites using High Performance Liquid Chromatography (HPLC) analysis. We found that 1.4%, 16.3% and 82.3% of the Emirati subjects were slow, intermediate and rapid CYP1A2 metabolizers, respectively. In addition, we found that 1.4% of the subjects were homozygote for derived alleles while 16.1% were heterozygote and 82.5% were homozygote for the ancestral allele. The genotype frequency of the ancestral allele, CYP1A2*1A/*1A, is the highest in this population, followed by CYP1A2 *1A/*1C and CYP1A2 *1A/*1K genotypes, with frequencies of 0.825, 0.102 and 0.058, respectively. The degree of phenotype/genotype concordance was equal to 81.6%. The CYP1A2*1C/*1C and CYP1A2*3/*3 genotypes showed significantly the lowest enzyme phenotypic activity. The frequency of slow activity CYP1A2 enzyme alleles is very low among Emiratis which correlates with the presence of low frequencies of derived alleles in CYP1A2 gene.